Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Belite Bio Inc

    NASDAQ: BLTE · Real-Time Price · USD
    60.06
    -2.08 (-3.35%)
    At close: Jun 13, 2025, 3:59 PM
    59.55
    -0.85%
    After-hours: Jun 13, 2025, 04:00 PM EDT

    Belite Bio Inc Statistics

    Share Statistics

    Belite Bio Inc has 32.54M shares outstanding. The number of shares has increased by 6.82% in one year.

    Shares Outstanding

    n/a
    		 32.54M

    Shares Change (YoY)

    n/a
    		 6.82%

    Shares Change (QoQ)

    n/a
    		 3.07%

    Owned by Institutions (%)

    n/a
    		 0.92%

    Shares Floating

    n/a
    		 14.99M

    Failed to Deliver (FTD) Shares

    n/a
    		 422

    FTD / Avg. Volume

    n/a
    		 1.27%

    Short Selling Information

    The latest short interest is 118.2K, so 0.37% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 118.2K

    Short % of Shares Out

    n/a
    		 0.37%

    Short % of Float

    n/a
    		 0.8%

    Short Ratio (days to cover)

    n/a
    		 2.99

    Valuation Ratios

    The PE ratio is -53.31 and the forward PE ratio is -38.63. Belite Bio Inc's PEG ratio is 63.44.

    PE Ratio

    n/a
    		 -53.31

    Forward PE

    n/a
    		 -38.63

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 7.8

    PB Ratio

    n/a
    		 13.21

    P/FCF Ratio

    n/a
    		 -65.58

    PEG Ratio

    n/a
    		 63.44
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Belite Bio Inc.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 24.31, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 24.31

    Quick Ratio

    n/a
    		 24.31

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 -1999.8

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,445,760

    Employee Count

    n/a
    		 25

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 6K

    Effective Tax Rate

    n/a
    		 -0.02%

    Stock Price Statistics

    The stock price has increased by 20.22% in the last 52 weeks. The beta is -1.45, so Belite Bio Inc's price volatility has been lower than the market average.

    Beta

    n/a
    		 -1.45

    52-Week Price Change

    n/a
    		 20.22%

    50-Day Moving Average

    n/a
    		 61.08

    200-Day Moving Average

    n/a
    		 60.88

    Relative Strength Index (RSI)

    n/a
    		 42.33

    Average Volume (20 Days)

    n/a
    		 33,273

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -449K

    Operating Income

    n/a
    		 -40M

    Net Income

    n/a
    		 -36.14M

    EBITDA

    n/a
    		 -35.67M

    EBIT

    n/a
    		 -36.12M

    Earnings Per Share (EPS)

    n/a
    		 -1.18
    Full Income Statement

    Balance Sheet

    The company has 31.68M in cash and 537K in debt, giving a net cash position of 31.14M.

    Cash & Cash Equivalents

    n/a
    		 31.68M

    Total Debt

    n/a
    		 537K

    Net Cash

    n/a
    		 31.14M

    Retained Earnings

    n/a
    		 -107.65M

    Total Assets

    n/a
    		 152.13M

    Working Capital

    n/a
    		 141.02M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -29.23M and capital expenditures -151K, giving a free cash flow of -29.39M.

    Operating Cash Flow

    n/a
    		 -29.23M

    Capital Expenditures

    n/a
    		 -151K

    Free Cash Flow

    n/a
    		 -29.39M

    FCF Per Share

    n/a
    		 -0.96
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    BLTE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for BLTE is $100, which is 66.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $100

    Price Target Difference

    n/a
    		 66.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 189.97

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist